I think SI is more than happy to conduct the extension trial together with the FDA.
Yes. As mentioned in this morning's phone conference, MSB will conduct an adult RCT against the current best treatment available (i.e. ruxolitinib). This is going to hurt the competition some more.
- Forums
- ASX - By Stock
- Ryoncil: ODAC/FDA Meeting Discussion
I think SI is more than happy to conduct the extension trial...
-
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.5¢ |
Change
-0.015(1.49%) |
Mkt cap ! $1.136B |
Open | High | Low | Value | Volume |
$1.02 | $1.02 | 99.5¢ | $2.005M | 1.991M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 14424 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 63643 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 14424 | 0.995 |
10 | 237639 | 0.990 |
3 | 56872 | 0.985 |
5 | 60954 | 0.980 |
2 | 20000 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 63643 | 1 |
1.005 | 15118 | 3 |
1.010 | 20000 | 2 |
1.015 | 92607 | 4 |
1.020 | 174044 | 9 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |